Advanced Optics Electronics Moves to Enhance Display Technology; Biomoda Scheduled for SB-2 Completion & poss JV with Genomed Inc.Business Editors ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Feb. 27, 2004 Indesign (Indianapolis, Ind.) has been retained by Advanced Optics Electronics Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: ADOT ADOT Arizona Department Of Transportation ADOT Alaska Department of Transportation ADOT Fédération des Associations pour le Don d'Organes et de Tissus Humains ADOT Active Duty Other Than Training ADOT Automatic Digital Optical Tracker ADOT Advanced Display Optimization Tools ) to increase the capabilities of ADOT's advanced sign development technology. Focus on enhancement will be directed to light sensitivity and video synchronicity synchronicity (singˈ·kr . Biomoda Inc. (30% directly and indirectly held by ADOT) has filed an additional patent relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc assay and protocol tests. Biomoda's pending SB-2 is slated for completion shortly after the company files its 10K for 2003. Advanced Optics Electronics Inc.'s 2003 10K is scheduled to be filed within the next 30 days. The company recently confirmed that outstanding debt continues to be greatly reduced. Net worth will reflect this fact and other positive developments. Advanced Optics currently holds approximately 16% of Biomoda Inc. as a direct investment and over 20%(a) of Genomed Inc., a publicly traded biotech company. A review has been commissioned and is now underway to determine the direction of a proposed joint venture in the near future involving both entities. (a) 14.2% as of 2/27/04; 20.3% after 3/15/04 Advanced Optics Electronics Inc. is a technology company based in Albuquerque, N.M. The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays A thin display screen for computer and TV usage. The first flat panels appeared on laptop computers in the mid-1980s, and the LCD technology became the standard. Stand-alone LCD screens became available for desktop computers in the mid-1990s and exceeded sales of CRTs for the first time utilizing its patented and patent pending technology. In addition to the core business of ADOT, the company has made a strategic technology-oriented investment in Biomoda Inc. Biomoda Inc. is a company that holds patents and patents pending domestically and internationally for the early detection of lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . ADOT currently holds directly and indirectly 30% of Biomoda Inc. This news release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates" and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion